Ning Li1, Thomas A Csepe1, Brian J Hansen1, Lidiya V Sul1, Anuradha Kalyanasundaram1, Stanislav O Zakharkin1, Jichao Zhao1, Avirup Guha1, David R Van Wagoner1, Ahmet Kilic1, Peter J Mohler1, Paul M L Janssen1, Brandon J Biesiadecki1, John D Hummel1, Raul Weiss1, Vadim V Fedorov2. 1. From Department of Physiology & Cell Biology, The Ohio State University Wexner Medical Center, Columbus (N.L., T.A.C., B.J.H., L.V.S., A. Kalyanasundaram, S.O.Z., A.G., P.J.M., P.M.L.J., B.J.B., V.V.F.); Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus (N.L., T.A.C., B.J.H., L.V.S., A. Kalyanasundaram, A. Kilic, P.J.M., P.M.L.J., B.J.B., J.D.H., R.W., V.V.F.); Auckland Bioengineering Institute, The University of Auckland, New Zealand (J.Z.); Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus (A.G., A. Kilic, P.J.M., P.M.L.J., J.D.H., R.W.); Department of Molecular Cardiology, Cleveland Clinic, OH (D.R.V.W.); and Department of Surgery, Division of Cardiac Surgery, Wexner Medical Center, The Ohio State University, Columbus (A. Kilic, J.D.H., R.W.). 2. From Department of Physiology & Cell Biology, The Ohio State University Wexner Medical Center, Columbus (N.L., T.A.C., B.J.H., L.V.S., A. Kalyanasundaram, S.O.Z., A.G., P.J.M., P.M.L.J., B.J.B., V.V.F.); Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus (N.L., T.A.C., B.J.H., L.V.S., A. Kalyanasundaram, A. Kilic, P.J.M., P.M.L.J., B.J.B., J.D.H., R.W., V.V.F.); Auckland Bioengineering Institute, The University of Auckland, New Zealand (J.Z.); Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus (A.G., A. Kilic, P.J.M., P.M.L.J., J.D.H., R.W.); Department of Molecular Cardiology, Cleveland Clinic, OH (D.R.V.W.); and Department of Surgery, Division of Cardiac Surgery, Wexner Medical Center, The Ohio State University, Columbus (A. Kilic, J.D.H., R.W.). vadim.fedorov@osumc.edu fedorov.2@osu.edu.
Abstract
BACKGROUND: Adenosine provokes atrial fibrillation (AF) with a higher activation frequency in right atria (RA) versus left atria (LA) in patients, but the underlying molecular and functional substrates are unclear. We tested the hypothesis that adenosine-induced AF is driven by localized reentry in RA areas with highest expression of adenosine A1 receptor and its downstream GIRK (G protein-coupled inwardly rectifying potassium channels) channels (IK,Ado). METHODS: We applied biatrial optical mapping and immunoblot mapping of various atrial regions to reveal the mechanism of adenosine-induced AF in explanted failing and nonfailing human hearts (n=37). RESULTS: Optical mapping of coronary-perfused atria (n=24) revealed that adenosine perfusion (10-100 µmol/L) produced more significant shortening of action potential durations in RA (from 290±45 to 239±41 ms, 17.3±10.4%; P<0.01) than LA (from 307±24 to 286±23 ms, 6.7±6.6%; P<0.01). In 10 hearts, adenosine induced AF (317±116 s) that, when sustained (≥2 minutes), was primarily maintained by 1 to 2 localized reentrant drivers in lateral RA. Tertiapin (10-100 nmol/L), a selective GIRK channel blocker, counteracted adenosine-induced action potential duration shortening and prevented AF induction. Immunoblotting showed that the superior/middle lateral RA had significantly higher adenosine A1 receptor (2.7±1.7-fold; P<0.01) and GIRK4 (1.7±0.8-fold; P<0.05) protein expression than lateral/posterior LA. CONCLUSIONS: This study revealed a 3-fold RA-to-LA adenosine A1 receptor protein expression gradient in the human heart, leading to significantly greater RA versus LA repolarization sensitivity in response to adenosine. Sustained adenosine-induced AF is maintained by reentrant drivers localized in lateral RA regions with the highest adenosine A1 receptor/GIRK4 expression. Selective atrial GIRK channel blockade may effectively treat AF during conditions with increased endogenous adenosine.
BACKGROUND:Adenosine provokes atrial fibrillation (AF) with a higher activation frequency in right atria (RA) versus left atria (LA) in patients, but the underlying molecular and functional substrates are unclear. We tested the hypothesis that adenosine-induced AF is driven by localized reentry in RA areas with highest expression of adenosine A1 receptor and its downstream GIRK (G protein-coupled inwardly rectifying potassium channels) channels (IK,Ado). METHODS: We applied biatrial optical mapping and immunoblot mapping of various atrial regions to reveal the mechanism of adenosine-induced AF in explanted failing and nonfailing human hearts (n=37). RESULTS: Optical mapping of coronary-perfused atria (n=24) revealed that adenosine perfusion (10-100 µmol/L) produced more significant shortening of action potential durations in RA (from 290±45 to 239±41 ms, 17.3±10.4%; P<0.01) than LA (from 307±24 to 286±23 ms, 6.7±6.6%; P<0.01). In 10 hearts, adenosine induced AF (317±116 s) that, when sustained (≥2 minutes), was primarily maintained by 1 to 2 localized reentrant drivers in lateral RA. Tertiapin (10-100 nmol/L), a selective GIRK channel blocker, counteracted adenosine-induced action potential duration shortening and prevented AF induction. Immunoblotting showed that the superior/middle lateral RA had significantly higher adenosine A1 receptor (2.7±1.7-fold; P<0.01) and GIRK4 (1.7±0.8-fold; P<0.05) protein expression than lateral/posterior LA. CONCLUSIONS: This study revealed a 3-fold RA-to-LAadenosine A1 receptor protein expression gradient in the human heart, leading to significantly greater RA versus LA repolarization sensitivity in response to adenosine. Sustained adenosine-induced AF is maintained by reentrant drivers localized in lateral RA regions with the highest adenosine A1 receptor/GIRK4 expression. Selective atrial GIRK channel blockade may effectively treat AF during conditions with increased endogenous adenosine.
Authors: S A Strickberger; K C Man; E G Daoud; R Goyal; K Brinkman; B P Knight; R Weiss; M Bahu; F Morady Journal: Ann Intern Med Date: 1997-09-15 Impact factor: 25.391
Authors: Amrish Deshmukh; John Barnard; Han Sun; David Newton; Laurie Castel; Gosta Pettersson; Douglas Johnston; Eric Roselli; A Marc Gillinov; Kenneth McCurry; Christine Moravec; Jonathan D Smith; David R Van Wagoner; Mina K Chung Journal: Circ Arrhythm Electrophysiol Date: 2014-12-18
Authors: Brian J Hansen; Jichao Zhao; Thomas A Csepe; Brandon T Moore; Ning Li; Laura A Jayne; Anuradha Kalyanasundaram; Praise Lim; Anna Bratasz; Kimerly A Powell; Orlando P Simonetti; Robert S D Higgins; Ahmet Kilic; Peter J Mohler; Paul M L Janssen; Raul Weiss; John D Hummel; Vadim V Fedorov Journal: Eur Heart J Date: 2015-06-08 Impact factor: 29.983
Authors: Maria S Guillem; Andreu M Climent; Jose Millet; Ángel Arenal; Francisco Fernández-Avilés; José Jalife; Felipe Atienza; Omer Berenfeld Journal: Circ Arrhythm Electrophysiol Date: 2013-02-26
Authors: Turhan Yavuz; Barry Bertolet; Yavuz Bebooul; Bulent Tunerir; Recep Aslan; Ahmet Ocal; Erdooan Ybribim; Ali Kutsal Journal: Clin Cardiol Date: 2004-06 Impact factor: 2.882
Authors: Sanjiv M Narayan; David E Krummen; Paul Clopton; Kalyanam Shivkumar; John M Miller Journal: J Am Coll Cardiol Date: 2013-04-03 Impact factor: 24.094
Authors: Miguel Rodrigo; Andreu M Climent; Alejandro Liberos; Francisco Fernández-Avilés; Omer Berenfeld; Felipe Atienza; Maria S Guillem Journal: Heart Rhythm Date: 2017-04-10 Impact factor: 6.343
Authors: Brian J Hansen; Jichao Zhao; Ning Li; Alexander Zolotarev; Stanislav Zakharkin; Yufeng Wang; Josh Atwal; Anuradha Kalyanasundaram; Suhaib H Abudulwahed; Katelynn M Helfrich; Anna Bratasz; Kimerly A Powell; Bryan Whitson; Peter J Mohler; Paul M L Janssen; Orlando P Simonetti; John D Hummel; Vadim V Fedorov Journal: JACC Clin Electrophysiol Date: 2018-11-01
Authors: Christopher A B Kowalewski; Fatemah Shenasa; Miguel Rodrigo; Paul Clopton; Gabriela Meckler; Mahmood I Alhusseini; Mark A Swerdlow; Vijay Joshi; Samir Hossainy; Junaid A B Zaman; Tina Baykaner; Albert J Rogers; Johannes Brachmann; John M Miller; David E Krummen; William H Sauer; Nicholas S Peters; Paul J Wang; Sanjiv M Narayan Journal: Circ Arrhythm Electrophysiol Date: 2018-06
Authors: George Leef; Fatemah Shenasa; Neal K Bhatia; Albert J Rogers; William Sauer; John M Miller; Mark Swerdlow; Mallika Tamboli; Mahmood I Alhusseini; Erin Armenia; Tina Baykaner; Johannes Brachmann; Mintu P Turakhia; Felipe Atienza; Wouter-Jan Rappel; Paul J Wang; Sanjiv M Narayan Journal: Circ Arrhythm Electrophysiol Date: 2019-07-29
Authors: Alexander M Zolotarev; Brian J Hansen; Ekaterina A Ivanova; Katelynn M Helfrich; Ning Li; Paul M L Janssen; Peter J Mohler; Nahush A Mokadam; Bryan A Whitson; Maxim V Fedorov; John D Hummel; Dmitry V Dylov; Vadim V Fedorov Journal: Circ Arrhythm Electrophysiol Date: 2020-09-13